Articles related to CLINICAL TRIALS

Recent findings suggest a link between daily low-dose aspirin intake and elevated anemia incidence and ferritin decline in older adults, highlighting the necessity for periodic monitoring of hemoglobin in these patients.

A phase II trial showed a significant progression-free survival benefit when patients with HR+/HER2- metastatic breast cancer switched endocrine therapy and received ribociclib, indicating the potential of this treatment strategy for those who progress on endocrine therapy and palbociclib. Learn more about the findings and implications for clinical practice.

The Low-PV phase 2 trial provides compelling evidence for the use of ropeginterferon alfa-2b in the management of low-risk Polycythemia vera, demonstrating its superiority over the standard treatment of therapeutic phlebotomy and aspirin in maintaining hematocrit levels and reducing disease-related symptoms.

Discover how a groundbreaking trial using a new CRISPR gene-editing technique has successfully treated a patient with T-cell leukemia, a form of the disease resistant to conventional treatments. Learn how this innovative approach could revolutionize the treatment of various diseases affecting the blood, bone marrow, and immune systems.

Aldeyra’s reproxalap shows considerable promise as a breakthrough treatment for ocular surface inflammatory conditions, highlighting its potential in addressing a significant unmet need in the field of optometry. Explore these groundbreaking clinical trial results.

Pioneering studies with clemastine, an over-the-counter antihistamine, are exhibiting groundbreaking findings in the repair of myelin, a protective coating on nerve fibers damaged in multiple sclerosis, based on ReBUILD clinical trial’s MRI data.